1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Montserret, R. Bartenschlager, R. Penin, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Plos Pathog. 1553-7366 6 e1001233 e1001233 10.1371/journal.ppat.1001233 21187906 Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. 2010 4275.298 Protease NS2-3 UNP residues 869-908 1 man polymer no no GRDAVILLTCAIHPELIFTITKILLAILGPLMVLQAGITK GRDAVILLTCAIHPELIFTITKILLAILGPLMVLQAGITK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HCV sample 11103 Hepatitis C virus Solution structure of Hepatitis C Virus NS2 protein segment 60-99 repository Initial release Version format compliance 1 0 2011-03-02 1 1 2011-07-13 BMRB Y RCSB 2010-04-22 REL REL structures with the least restraint violations 50 41 2D 1H-1H NOESY 2D 1H-1H TOCSY 2D 1H-13C HSQC 0.4 mM 50 % [U-2H] 50 % 0.2 uM 0 6.0 ambient 298 K torsion angle dynamics 1 closest to the average 0.4 mM NS2[60-99], 50 % v/v [U-2H] TFE, 50 % v/v H2O, 0.2 uM DSS, trifluoroethanol/water trifluoroethanol/water Bruker Biospin collection TOPSPIN Goddard data analysis SPARKY Schwieters, Kuszewski, Tjandra and Clore structure solution X-PLOR_NIH 2.24 Schwieters, Kuszewski, Tjandra and Clore refinement X-PLOR_NIH 2.24 500 Bruker Avance Bruker Avance GLY 1 n 1 GLY 1 A ARG 2 n 2 ARG 2 A ASP 3 n 3 ASP 3 A ALA 4 n 4 ALA 4 A VAL 5 n 5 VAL 5 A ILE 6 n 6 ILE 6 A LEU 7 n 7 LEU 7 A LEU 8 n 8 LEU 8 A THR 9 n 9 THR 9 A CYS 10 n 10 CYS 10 A ALA 11 n 11 ALA 11 A ILE 12 n 12 ILE 12 A HIS 13 n 13 HIS 13 A PRO 14 n 14 PRO 14 A GLU 15 n 15 GLU 15 A LEU 16 n 16 LEU 16 A ILE 17 n 17 ILE 17 A PHE 18 n 18 PHE 18 A THR 19 n 19 THR 19 A ILE 20 n 20 ILE 20 A THR 21 n 21 THR 21 A LYS 22 n 22 LYS 22 A ILE 23 n 23 ILE 23 A LEU 24 n 24 LEU 24 A LEU 25 n 25 LEU 25 A ALA 26 n 26 ALA 26 A ILE 27 n 27 ILE 27 A LEU 28 n 28 LEU 28 A GLY 29 n 29 GLY 29 A PRO 30 n 30 PRO 30 A LEU 31 n 31 LEU 31 A MET 32 n 32 MET 32 A VAL 33 n 33 VAL 33 A LEU 34 n 34 LEU 34 A GLN 35 n 35 GLN 35 A ALA 36 n 36 ALA 36 A GLY 37 n 37 GLY 37 A ILE 38 n 38 ILE 38 A THR 39 n 39 THR 39 A LYS 40 n 40 LYS 40 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 2 0.254 SIDE CHAIN 2 A ARG 2 0.311 SIDE CHAIN 3 A ARG 2 0.317 SIDE CHAIN 4 A ARG 2 0.314 SIDE CHAIN 5 A ARG 2 0.291 SIDE CHAIN 6 A ARG 2 0.317 SIDE CHAIN 7 A ARG 2 0.299 SIDE CHAIN 8 A ARG 2 0.258 SIDE CHAIN 9 A ARG 2 0.317 SIDE CHAIN 10 A ARG 2 0.301 SIDE CHAIN 11 A ARG 2 0.317 SIDE CHAIN 12 A ARG 2 0.314 SIDE CHAIN 13 A ARG 2 0.305 SIDE CHAIN 14 A ARG 2 0.307 SIDE CHAIN 15 A ARG 2 0.315 SIDE CHAIN 16 A ARG 2 0.316 SIDE CHAIN 17 A ARG 2 0.314 SIDE CHAIN 18 A ARG 2 0.317 SIDE CHAIN 19 A ARG 2 0.317 SIDE CHAIN 20 A ARG 2 0.315 SIDE CHAIN 21 A ARG 2 0.315 SIDE CHAIN 22 A ARG 2 0.296 SIDE CHAIN 23 A ARG 2 0.294 SIDE CHAIN 24 A ARG 2 0.313 SIDE CHAIN 25 A ARG 2 0.317 SIDE CHAIN 26 A ARG 2 0.262 SIDE CHAIN 27 A ARG 2 0.312 SIDE CHAIN 28 A ARG 2 0.312 SIDE CHAIN 29 A ARG 2 0.304 SIDE CHAIN 30 A ARG 2 0.318 SIDE CHAIN 31 A ARG 2 0.315 SIDE CHAIN 32 A ARG 2 0.312 SIDE CHAIN 33 A ARG 2 0.318 SIDE CHAIN 34 A ARG 2 0.317 SIDE CHAIN 35 A ARG 2 0.316 SIDE CHAIN 36 A ARG 2 0.312 SIDE CHAIN 37 A ARG 2 0.308 SIDE CHAIN 38 A ARG 2 0.311 SIDE CHAIN 39 A ARG 2 0.318 SIDE CHAIN 40 A ARG 2 0.295 SIDE CHAIN 41 A ARG 2 0.315 SIDE CHAIN 1 A ARG 2 -110.48 -169.17 1 A ALA 4 -172.62 -50.13 2 A ILE 27 -114.42 56.19 2 A LEU 28 -100.17 -62.60 3 A ALA 4 -173.62 -53.84 3 A ALA 11 -100.05 43.74 3 A GLN 35 -147.46 26.69 4 A ALA 4 -176.71 -50.09 4 A HIS 13 56.19 75.18 4 A PRO 14 -74.53 -169.62 4 A LEU 16 -174.51 -58.62 5 A THR 39 -150.45 59.99 6 A ARG 2 -108.30 42.94 6 A ALA 11 -99.23 44.86 6 A HIS 13 -158.59 66.24 6 A ALA 36 -100.46 -64.05 6 A THR 39 -112.46 50.47 7 A ARG 2 -109.74 -161.55 7 A ALA 4 -171.32 -57.45 7 A THR 39 -145.75 44.66 8 A PRO 14 -64.40 -167.04 8 A LEU 16 -171.64 -53.78 9 A ALA 11 -117.19 58.50 9 A ILE 27 -125.52 -53.06 9 A ALA 36 -103.85 70.69 9 A THR 39 -153.03 72.10 10 A LEU 16 -132.41 -50.08 10 A THR 39 -161.44 42.12 11 A LEU 16 -165.45 -55.70 11 A ILE 27 -130.38 -57.32 12 A HIS 13 66.36 94.01 12 A ILE 27 -96.87 -69.18 12 A THR 39 -154.37 53.66 13 A PRO 30 -86.63 40.65 13 A THR 39 -105.73 47.63 14 A LEU 28 -118.77 -72.91 14 A GLN 35 -149.52 27.09 14 A THR 39 -157.23 32.06 15 A LEU 16 -169.65 -55.75 15 A THR 39 -150.07 66.94 16 A HIS 13 62.79 97.49 16 A LEU 16 -151.44 -53.88 16 A GLN 35 -141.09 29.41 16 A THR 39 -108.39 41.77 17 A ILE 27 -137.18 -51.41 18 A LEU 8 -100.74 -86.75 18 A HIS 13 62.60 83.33 19 A LEU 8 -96.70 35.18 19 A LEU 28 -97.71 47.48 19 A GLN 35 -149.24 24.53 19 A THR 39 -156.22 39.63 20 A ASP 3 -121.25 -59.57 20 A HIS 13 -168.82 64.21 20 A PRO 30 -70.30 -83.34 20 A MET 32 -175.24 -55.02 20 A GLN 35 -161.39 33.65 21 A ALA 4 -173.18 -52.54 21 A ALA 11 -118.44 -72.42 21 A ILE 12 56.71 18.86 22 A ASP 3 -167.53 -61.58 22 A ILE 38 -102.12 57.02 22 A THR 39 -163.78 59.93 23 A ARG 2 -115.51 -166.99 23 A ALA 4 -178.35 -47.77 23 A ILE 27 -128.89 -50.77 24 A ASP 3 -131.14 -58.94 24 A ILE 12 55.47 -178.72 24 A GLN 35 -144.53 25.22 25 A ALA 36 -101.20 79.31 25 A ILE 38 -95.67 34.68 25 A THR 39 -115.13 50.72 26 A ALA 4 -174.66 -51.79 26 A ALA 11 -98.25 42.35 26 A ILE 27 -139.14 -51.98 27 A ALA 4 -173.54 -55.23 27 A ILE 12 -63.65 -173.81 27 A PRO 14 -67.54 -160.90 27 A LEU 16 -144.10 -53.87 27 A LEU 28 -157.18 76.20 27 A GLN 35 -150.45 26.00 27 A THR 39 -144.40 -54.56 28 A ALA 11 -101.29 46.83 28 A HIS 13 67.21 106.86 28 A ILE 27 -109.25 48.40 28 A GLN 35 -146.49 24.88 28 A ILE 38 -114.87 50.40 28 A THR 39 -154.55 49.82 29 A ILE 27 -126.93 -52.71 29 A LEU 28 57.83 71.58 29 A GLN 35 -141.89 31.14 29 A THR 39 -145.96 -72.51 30 A ALA 11 -94.16 35.21 30 A LEU 16 -167.75 -51.09 30 A PRO 30 -93.36 53.56 30 A THR 39 -107.97 48.35 31 A ALA 36 -107.26 57.76 32 A CYS 10 -95.66 37.23 32 A ALA 11 -157.74 38.24 32 A GLN 35 -152.53 29.26 33 A ALA 4 -175.13 -52.55 33 A ILE 27 -128.32 -53.35 34 A ILE 12 58.49 91.46 34 A PRO 14 -65.02 -177.34 34 A LEU 16 -152.10 -53.89 34 A THR 39 -152.23 67.24 35 A ALA 11 -105.72 50.58 35 A HIS 13 -151.08 66.23 35 A LEU 28 -106.72 -74.61 35 A THR 39 -110.07 51.50 36 A LEU 16 -159.67 -51.12 36 A LEU 28 -87.20 30.94 37 A ASP 3 -161.88 -64.99 37 A ALA 36 -107.25 76.31 38 A ALA 11 -113.94 -70.53 38 A ILE 12 40.29 29.63 38 A HIS 13 60.60 92.18 38 A THR 39 -108.74 42.76 39 A LEU 16 -174.65 -51.78 39 A ALA 36 -103.65 76.11 40 A HIS 13 -150.33 59.30 40 A GLU 15 59.66 13.96 40 A LEU 16 -143.04 -59.76 40 A ILE 27 -120.97 -69.20 40 A THR 39 -112.94 54.28 41 A ARG 2 -102.61 -165.98 41 A ALA 4 -170.72 -54.03 41 A PRO 30 -90.14 38.19 Protease NS2-3 closest to the average, model 1 Solution structure of NS2 [60-99] 1 N N A ALA 4 A ALA 4 HELX_P A ILE 12 A ILE 12 1 1 9 A HIS 13 A HIS 13 HELX_P A ILE 27 A ILE 27 1 2 15 A GLY 29 A GLY 29 HELX_P A LEU 34 A LEU 34 1 3 6 VIRAL PROTEIN Hepatitis C Virus, NS2 domain, Viral protein, membrane protein POLG_HCVCO UNP 1 869 Q9WMX2 GRDAVILLTCAIHPELIFTITKILLAILGPLMVLQAGITK 869 908 2KWZ 1 40 Q9WMX2 A 1 1 40